Give Eye Center of New York a phone call at (332) 263-4449
Request an Appointment

A Breakthrough in EDOF Technology

The TECNIS PureSee IOL represents a significant advancement in extended depth of focus lens technology. Approved by the FDA in March 2026, this purely refractive EDOF lens is the first and only FDA-approved EDOF IOL without a warning regarding loss of contrast sensitivity. Dr. Tal Raviv, MD, FACS, is among the first surgeons in Manhattan to offer this lens, beginning implantation the week it becomes commercially available in April 2026.

Built on Johnson & Johnson's proven TECNIS platform, the same technology behind the popular Odyssey, Symfony, and Eyhance lenses, the PureSee uses advanced optics and proprietary materials to extend your range of vision while maintaining the visual clarity typically associated with monofocal lenses.

Dr Raviv smiling next to flowers
Background image pattern

Dr. Raviv's Take:

Pros:

  • Excellent contrast sensitivity comparable to a monofocal IOL, the only FDA-approved EDOF lens without a contrast sensitivity warning
  • 97% of patients reported no very bothersome visual disturbances such as halos or glare
  • Provides clear distance and intermediate vision (computer, dashboard, cooking) with some near vision
  • Purely refractive design means fewer nighttime visual disturbances than diffractive EDOF lenses
  • Built on the trusted TECNIS platform with 25 years of proven performance
  • Also available in a toric version to correct astigmatism
  • 97% of patients in clinical trials would recommend this lens to friends or family

Cons:

  • Most patients will still need light readers for very fine print or extended close-up reading
  • Like all premium IOLs, a small percentage of patients may benefit from a laser touch-up (such as PRK) at about three months post-op to optimize their vision
  • Not a multifocal lens, patients seeking maximum near vision independence may prefer the TECNIS Odyssey

How Does TECNIS PureSee Compare to Other IOLs?

The PureSee occupies an important space in the IOL spectrum, it offers more range of vision than a monofocal or enhanced monofocal (like the Eyhance) while producing fewer visual disturbances than a full multifocal (like the Odyssey or PanOptix).

PureSee vs. Eyhance (enhanced monofocal): Clinical studies show the PureSee provides superior intermediate and near vision compared to the Eyhance, while maintaining comparable distance vision and contrast sensitivity.

PureSee vs. Vivity (another EDOF): Both lenses target distance and intermediate vision. The PureSee is the only EDOF without an FDA warning about contrast sensitivity loss, and 97% of patients report no very bothersome visual disturbances.

PureSee vs. Odyssey (multifocal): The Odyssey provides a fuller range of vision including near, but with more potential for nighttime halos. The PureSee offers a more monofocal-like visual quality with fewer disturbances, ideal for patients who prioritize crisp vision and low dysphotopsia over complete spectacle independence.

Who Is a Good Candidate for TECNIS PureSee?

Dr. Raviv places this IOL in cataract surgery or RLE patients who:

  • Want excellent distance and intermediate vision with minimal visual disturbances
  • Prioritize high-quality, crisp vision similar to a monofocal lens
  • Are comfortable using light readers for extended close-up tasks or small print
  • Have otherwise healthy eyes with 20/20 visual potential
  • Want to reduce dependence on glasses for most daily activities
  • May be sensitive to halos or glare and want to minimize these effects
  • Have a lifestyle focused on driving, computer work, and general daily activities rather than extensive fine-print reading

Logo media

What Makes TECNIS PureSee Different?

This innovative optical design allows the lens to:

  • Maintain contrast sensitivity comparable to an aspheric monofocal IOL
  • Minimize dysphotopsia (unwanted visual effects like halos and glare)
  • Extend the range of vision beyond what a standard monofocal can achieve
  • Deliver improved intermediate visual acuity compared to enhanced monofocal lenses
Banner media

Worldwide Experience, Now Available in New York

While newly FDA-approved in the United States, the TECNIS PureSee has been available internationally and has already been implanted in nearly half a million eyes worldwide. This extensive global experience provides additional confidence in the lens's safety and effectiveness.

At the Eye Center of New York, Dr. Raviv brings over 20 years of experience in premium cataract surgery and access to the latest IOL technologies. His expertise with the entire TECNIS platform, including the Eyhance, Symfony, and Odyssey, positions him to help you determine whether the PureSee is the right choice for your eyes and lifestyle.

FAQ

What is the difference between the PureSee and a monofocal IOL?

Will I still need glasses after PureSee implantation?

How does PureSee handle nighttime driving?

Is PureSee available in a toric version for astigmatism?

How does Dr. Raviv decide which IOL is right for me?

What if my vision isn't perfect after surgery?

Background media

What is the difference between the PureSee and a monofocal IOL?

A standard monofocal IOL provides clear vision at one distance only (typically distance), requiring glasses for intermediate and near tasks. The PureSee extends your range of vision to include excellent distance and intermediate vision, reducing your dependence on glasses for activities like computer use, cooking, and viewing your car dashboard.

Will I still need glasses after PureSee implantation?

Most patients achieve good functional vision for distance and intermediate tasks without glasses. However, light over-the-counter readers are typically helpful for very fine print or extended close-up reading. The goal is to significantly reduce—not completely eliminate—your dependence on glasses.

How does PureSee handle nighttime driving?

One of the PureSee's key advantages is its excellent nighttime visual profile. In clinical studies, 97% of patients reported no very bothersome visual disturbances. The purely refractive design produces fewer halos and glare around headlights and streetlights compared to diffractive or multifocal lenses.

Is PureSee available in a toric version for astigmatism?

Yes, the TECNIS PureSee Toric II IOL is available for patients with corneal astigmatism of 1 diopter or greater. Dr. Raviv will determine whether a toric version is indicated based on your preoperative measurements.

How does Dr. Raviv decide which IOL is right for me?

During your comprehensive evaluation at the Eye Center of New York, Dr. Raviv uses advanced diagnostic technology to assess your eye anatomy, lifestyle needs, and visual goals. He will discuss all appropriate options—including monofocal, EDOF (like PureSee or Vivity), multifocal (like Odyssey or PanOptix), and the Light Adjustable Lens—to help you make an informed decision.

What if my vision isn't perfect after surgery?

As with all premium IOLs, a small percentage of patients may benefit from a fine-tuning procedure such as PRK at about three months post-op. At the Eye Center of New York, approximately 3% of premium IOL patients undergo laser vision enhancement to optimize their results.

Schedule Your Consultation

The TECNIS PureSee IOL offers a compelling option for patients seeking high-quality vision with an extended range and minimal visual disturbances. Dr. Tal Raviv, MD, FACS, brings decades of experience in premium cataract surgery to help you determine if this breakthrough lens technology is right for you.

Contact the Eye Center of New York to schedule your cataract evaluation and learn more about your IOL options.

Schedule Your Appointment Your Vision Awaits

Request an Appointment
Contact us media
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (332) 263-4449.
Request an Appointment